Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | NY-ESO-1 TCR/IL-15 NK cells |
| Synonyms | |
| Therapy Description |
NY-ESO-1 TCR/IL-15 NK cells are allogeneic natural killer (NK) cells derived from cord blood that are engineered to express a T-cell receptor (TCR) targeting NY-ESO-1 and to express IL-15, which potentially induce toxicity in tumor cells expressing NY-ESO-1 (NCI Drug Dictionary). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| NY-ESO-1 TCR/IL-15 NK cells | Allogeneic anti-NY-ESO-1 TCR-transduced IL-15-expressing CB-derived NK cells | NY-ESO-1 TCR/IL-15 NK cells are allogeneic natural killer (NK) cells derived from cord blood that are engineered to express a T-cell receptor (TCR) targeting NY-ESO-1 and to express IL-15, which potentially induce toxicity in tumor cells expressing NY-ESO-1 (NCI Drug Dictionary). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|